Non-Pharmacological Management of Cardiac Arrhythmias

Abstract

Get full access to this article

View all access options for this article.

References

Adgey

Johnstone

Mathew

. Sudden cardiac death - a predictable, avoidable and treatable event. Proc R Coll Physicians Edinb 1998; 29:350–6.

Haissaguerre

Shah

Jais

. Role of catheter ablation for atrial fibrillation. Curr Opin Cardiol 1997, 12:18–23.

Haissaguerre

Gencel

Fischer

. Successful catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 1994; 5:1045–52.

Swartz

Pellersels

Silvers

. Catheter-based curative approach to atrial fibrillation in humans. Circulation 1994; 90(Suppl 1):I335.

Haissaguerre

Jais

Shah

. Right and left atrial radiofrequency catheter ablative therapy of paroxysmal atrial fibrillation. J Cardiovasc. Electrophysiol 1994; 7:132–44.

Jais

Haissaguerre

Shah

. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997; 95:572–6.

Haissaguerre

Jais

Shah

. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339:659–66.

Xie

Katrittsis

Heald

. Localisation of accessory pathways from the 12 lead ECG using a new algorithm. Am J Cardiol 1994; 74:161–5.

Fitzpatrick

Gonzales

Lesh

. New algorithm for the localisation of accessory atrioventricular connections using a baseline electocardiogram. J Am Coll Cardiol 1994; 23:107–16.

10.

Milstein

Sharma

Guiraudon

. An algorithm for the elecrocardiographic localisation of accessory pathways in the Wolff-Parkinson-White Syndrome. PACE 1987; 10:555–63.

11.

Linsay

Crossen

Cain

. Concordance of distinguishing electrocardiographic features during sinus rhythm with the localisation of accessory pathways in the Wolff-Parkinson-White Syndrome. Am J Cardiol 1987; 59: 1093–102.

12.

Scheinman

. Patterns of catheter ablation practice in the United States: Results of the 1992 NASPE survey. PACE 1994; 17:873–83.

13.

Hindricks

On behalf of the Multicentre European Radiofrequency Survey (MERFS) Investigators of the Working Group on Arrhythmias of the European Society of Cardiology. The Multicentre European Radiofrequency Survey (MERFS): Complications of radiofrequency catheter ablation of arrhythmias. Eur Heart J 1993; 14:1644–53.

14.

Moe

Preston

Burlington

. Physiologic evidence for a dual A-V transmission. Circ Res 1956; 4:357–75.

15.

Zhu

DHW

Maloney

. Radiofrequency catheter ablative therapy for atrioventricular nodal re-entrant tachycardia. In: Interventional electrophysiology Williams and Wilkins, 1997; 275–316.

16.

Gaita

Riccardi

Calo

. Importance and implications of AV block following radiofrequency ablation. Heart 1998; 79:534–5.

17.

Jackman

Beckman

McCleland

. Treatment of supraventricular tachycardia due to AV nodal reentry by radiofrequency catheter ablation of slow pathway conduction. N Engl J Med 1992; 327:313–9.

18.

Haissaguerre

Gaita

Fisher

. Elimination of AV nodal re-entrant tachycardia using discrete slow potentials to guide application of radiofrequency energy. Circulation 1992; 85:2162–75.

19.

Olshansky

Wilber

Hariman

. Atrial flutter - update on the mechanism and treatment. PACE 1992; 15:2308–35.

20.

Lesh

Kalman

Olgin

. An electrophysiological approach to catheter ablation of atrial flutter and tachycardia: from mechanism to practice. In: Interventional electrophysiology. Williams and Wilkins, 1997; 347–82.

21.

Lesh

Van Hare

Epstein

. Radiofrequency catheter ablation of atrial arrhythmias. Results and mechanisms. Circulation 1994; 89:1074–89.

22.

Allessie

Koning

Kirchhof

. Electrophysiological mechanisms of perpetuation of atrial fibrillation. Am J Cardiol 1996; 77:10A-23A.

23.

Brignole

Gianfranchi

Menozzi

. An assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation. A randomised controlled study. Circulation 1997; 96:2617–262.

24.

Kay

Bubien

Epstein

. Effect of catheter ablation of the atrioventricular junction on quality of life and exercise tolerance in paroxysmal atrial fibrillation. Am J Cardiol 1988; 62:741–4.

25.

Fitzpatrick

Kourouyan

Siu

. Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: impact of treatment in paroxysmal and established atrial fibrillation. Am Heart J 1996; 131:499–507.

26.

Marshall

Harris

Griffith

. Atrioventricular nodal ablation and implantation of mode switching dual chamber pacemakers: effective treatment for drug refractory paroxysmal atrial fibrillation. Heart 1998; 79:543–7.

27.

Kamalvand

Tan

Kotsakis

. Is mode switching beneficial? A randomised study in patients with paroxysmal tachyarrhythmias. J Am Coll Cardiol 1997; 30:496–504.

28.

Feld

Fleck

Fujmura

. Control of rapid ventricular response by radiofrequency catheter modification of the atrioventricular node in patients with medically refractory atrial fibrillation. Circulation 1994; 90:2299–307.

29.

Williamson

Man

Daoud

. Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation. N Engl J Med 1994; 331:910–6.

30.

Twidale

Mcdonald

Nave

. Comparison of the effects of AV node ablation versus AV nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation. PACE 1998; 21:641–51.

31.

Canby

Roman

Kessler

. Selective radiofrequency ablation of the ‘slow’ atrioventricular nodal pathway for control of the ventricular response to atrial fibrillation. Am J Cardiol 1996; 77:1358–61.

32.

Morady

Hasse

Stickberger

. Long term follow-up after radiofrequency modification of the atrioventricular node in patients with atrial fibrillation. J Am Coll Cardiol 1997; 29:113–21.

33.

Lee

Chen

Tai

. Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation. J Am Coll Cardiol 1998; 31:637–44.

34.

Moe

. On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther 1962; 140:183–8.

35.

Giraudon

Campbell

Jones

. Combined sino atrial node atrio-ventricular isolation: a surgical alternative to His bundle ablation in patients with atrial fibrillation. Circulation 1985; 72 (suppl III):III-220.

36.

Cox

Schuessler

D'Agostino

. The surgical treatment of atrial fibrillation: III. Development of a definitive surgical procedure. J Thoracic Cardiovasc Surg 1991; 101:569–83.

37.

Cox

Schuessler

Lappas

. An 8+ year clinical experience with surgery for atrial fibrillation. Ann Surg 1996; 224:267–73.

38.

Doevendans

Wellens

HJJ

. Atrial dissection for atrial fibrillation: when, how much and where? J Am Coll Cardiol 1996; 28:991–3.

39.

Beck

Pritchard

Feil

. Ventricular fibrillation of long duration abolished by electrical shock. JAMA 1947; 135:985–86.

40.

Lown

Amarasinghem

Neuman

. New methods for terminating cardiac arrhythmias: use of synchronised capacitor discharge. JAMA 1962; 182:548–55.

41.

Van Gelder

Crijns

Tieleman

. Value and limitation of electrical cardioversion in patients with chronic atrial fibrillation - importance of arrhythmia risk factors and oral anticoagulation. Arch Intern Med 1996; 156:2585–92.

42.

Van Gelder

. Crijns HJ. Cardioversion of atrial fibrillation and subsequent maintenance of sinus rhythm. PACE 1997; 20:2675–83.

43.

Gosselink

ATM

Crijns

Van gelder

. Low dose Amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAMA 1992; 267:3289–93.

44.

Horowitz

Spielman

Greenspan

. Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to Quinidine therapy. J Am Coll Cardiol 1985; 6:1402–7.

45.

Mayet

. More RS. Sutton GC. Anticoagulation for cardioversion of atrial arrhythmias. Eur Heart J 1998; 19:548–52.

46.

Neumayr

Schratzberger

Friedrich

. Effect of electrical cardioversion on myocardial cells in patients in intensive care. BMJ 1998; 316:1207.

47.

Georges

Spentchian

Caubel

. Time course of troponin I, myoglobin and cardiac enzyme release after electrical cardioversion. Am J Cardiol 1996; 78:825–6.

48.

Levy

Lauribe

Dolla

. A randomised comparison of external and internal cardioversion of atrial fibrillation. Circulation 1992; 86: 1415–20.

49.

The AVID Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576–83.

50.

Moss

Hall

Cannom

. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335:1933–40.

51.

Jung

Luderitz

. Implantable atrial defibrillators: Quo Vadis? PACE 1997; 20:2141–5.

52.

Ayres

Griffin

. The future role of defibrillators in the management of atrial fibrillation. Current Opinion in Cardiology 1997; 12:12–17.

53.

Saksena

Mongeon

Krol

. Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations. Am J Cardiol 1995; 76:913–21.

54.

Murgatroyd

Slade

AKB

Sopher

. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol 1995; 25:1347–53.

55.

Jung

Luderitz

. Implantation of an arrhythmia management system for ventricular and supraventricular tachyarrhythmias. Lancet 1997; 349:853–4.

56.

Jung

Kirchhoff

Lau CP for the Metrix System Clinical Investigational Group. Therapy delivery with the METRIX automatic atrial defibrillator system: threshold stability and shock safety. J Am Coll Cardiol 1997; 29:78A.